Advanced Oxygen Therapy Inc. (AOTI) AOTI is focused on advancing health equity and addressing outcome disparities in patients with nonhealing wounds with its unique evidence based Topical Wound Oxygen (TWO2) therapy. AOTI has proudly served the Veteran community as a Federal Supply Schedule contract holder for over 10 years. Helping to heal the wounds and save the limbs of over 20,000 patients, with over 2 million TWO2 treatments applied by patients safely at home.

TWO2 therapy is unique in that it has been proven in rigorous clinical trials conducted within the VA to provide much higher and more durable complete healing outcomes for Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU), which disproportionately afflict ethnic and low socio-economic minority populations. Leading RCT and RWE studies have demonstrated that TWO2 provides a significant 6-fold reduction in ulcer reoccurrence, resulting in a 9-fold reduction in hospitalizations and 5-fold reduction in amputations, over 12 months.

These outcomes have an enormous impact on the patient’s quality and even duration of life, as well as providing for significant cost saving benefits. The COVID-19 pandemic has only further emphasized the importance of proven effective home care modalities for these comorbid and high-risk patient populations.

Website: https://www.aotinc.net